PARADEEP NSE filing

Paradeep Phosphates FY26 Revenue Jumps 29% to ₹21,826 Cr; PAT Up 52% to ₹1,000 Cr

The RealCase readHigh impact Positive

Paradeep Phosphates Ltd reported FY26 revenue up 29% to ₹21,826 crore and PAT up 52% to ₹1,000 crore. Q4 FY26 revenue was ₹4,702 crore. Production grew 8% to 36.66 LMT, sales up 10% to 42.10 LMT. Commissioned new Sulphuric Acid plants and progressing phos acid capacity expansion.

Why it matters

The significant increase in financial metrics, capacity expansions, and positive outlook on future growth suggest a high impact on the company's performance and investor sentiment.

The market read

The company reported strong year-on-year growth in revenue, EBITDA, PBT, and PAT, along with increased production and sales volumes. The commissioning of new plants and progress on capacity expansion indicate positive future prospects.

Paradeep Phosphates Limited (PPL) announced its financial results for the quarter and year ended March 31, 2026. The company reported a significant year-on-year growth, with revenue from operations increasing by 29% to ₹21,826 crore in FY26. EBITDA rose by 33% to ₹2,259 crore, while Profit Before Tax (PBT) saw a 46% increase to ₹1,328 crore. Profit After Tax (PAT) stood at ₹1,000 crore, marking a substantial 52% year-on-year growth.

For the fourth quarter of FY26, PPL reported revenue of ₹4,702 crore, EBITDA of ₹484 crore, PBT of ₹202 crore, and PAT of ₹161 crore.

Production volumes grew by 8% year-on-year to 36.66 LMT in FY26, with sales volumes rising by 10% to 42.10 LMT. This growth was primarily driven by strong performance in value-added NPK grades, which saw a 22% year-on-year increase to 24.64 LMT.

Despite global uncertainties, raw material price volatility, and INR depreciation, PPL maintained a consistent and robust performance through operational agility, backward integration, and supply chain efficiencies.

Mr. N. Suresh Krishnan, Managing Director & CEO, commented on the results, highlighting the company's integrated operations and resilience. He noted the achievement of 3.67 MMTPA fertilizer production in FY26, near 100% capacity utilization. During FY26, PPL commissioned a Sulphuric Acid Plant at Paradeep (500,000 MTPA) and another at Mangalore (100,000 MTPA), increasing its Sulphuric Acid capacity by 0.6 MMTPA (45%). The plan to double phos acid capacity from 0.5 MMTPA to 1 MMTPA is on track, with Phase 1 expansion at Paradeep expected to be commissioned in FY27.

Krishnan also mentioned the 22% growth in NPK sales (including TSP) in FY26, supported by a strong distribution network across 18 states and brand equity. The company remains committed to offering innovative NPK grades and optimizing last-mile delivery through digital interventions. The enhanced long-term credit rating of AA-(stable) is expected to aid in optimizing working capital and finance costs.

Sustainability is a core focus, with PPL achieving an S&P Global ESG score of 76 in FY26, ranking in the top 2% globally in the Chemical Sector.

Looking ahead, PPL aims to drive growth through operational excellence, product innovation, and disciplined execution, focusing on creating shareholder value.

Filing to action

What to do with a filing like this

Paradeep Phosphates Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Paradeep Phosphates Limited. Read the original for the full detail.

View original filing